![Florent Aptel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Florent Aptel
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Eye Tech Care SA
![]() Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France.
8
| Holding Company | Medical Specialties | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Florent Aptel
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Founder Corporate Officer/Principal | |
Themis Bioscience GmbH
![]() Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BioVex, Inc.
![]() BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
École Centrale Paris | College/University | Undergraduate Degree | |
Ventech SA
![]() Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US. | Investment Managers | Private Equity Investor | |
EDAP TMS S.A. | Medical Specialties | Corporate Officer/Principal | |
Ecole Supérieure de l'Energie et des Matériaux | College/University | Undergraduate Degree | |
Covidien LP
![]() Covidien LP Medical SpecialtiesHealth Technology Covidien LP manufactures and distributes medical devices. Its products include disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. The company is headquartered in Mansfield, MA. | Medical Specialties | Corporate Officer/Principal | |
Xenocs SAS
![]() Xenocs SAS Medical SpecialtiesHealth Technology Xenocs SA designs, develops and manufactures x-ray optics and x-ray optical components. It provides solutions for x-ray material analysis. The firm offers x-ray optics and optical components, fluorescence analyzers and beam delivery systems. The company was founded by Peter Høghøj and Frédéric Bossan in 2000 and is headquartered in Sassenage, France. | Medical Specialties | Director/Board Member | |
Exonet
![]() Exonet Packaged SoftwareTechnology Services Part of MYOB Group Pty Ltd., Exonet is a New Zealander company that develops business management software. The company is based in Auckland, New Zealand. The company was founded by Mark Clampitt Loveys. Exonet was acquired by MYOB Ltd. on January 05, 2007 for $2.30 million. | Packaged Software | Director/Board Member | |
TopAchat.com
![]() TopAchat.com Internet Software/ServicesTechnology Services Part of Groupe LDLC SA, TopAchat.com is a French company that operates a website retailing multimedia products. The company was founded by Denis Gachon. TopAchat.com was acquired by Groupe LDLC SA from Carrefour SA on April 10, 2020. | Internet Software/Services | Director/Board Member | |
Sharing Technologies | Director/Board Member | ||
Trace One SAS
![]() Trace One SAS Packaged SoftwareTechnology Services Trace One SA provides e-collaborative solutions for private label. It specializes in retail, food safety, product development, private label collaboration platform, collaborative retail network, consumer packaged goods. The company was founded by Jérôme Malavoy in 2001 and is headquartered in Paris, France. | Packaged Software | Director/Board Member | |
Stethos SA
![]() Stethos SA Miscellaneous Commercial ServicesCommercial Services Stethos SA operates as a international market research company that focuses on the healthcare sector. The company was founded in 1996 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
OROS SAS
![]() OROS SAS Electronic Equipment/InstrumentsElectronic Technology OROS SAS designs and manufactures noise and vibration signal analyzers. It provides customization, maintenance, rental, measurement and diagnostics, and training services. It offers its solutions to the automobile, aerospace, energy, and shipbuilding industries. The company was founded by Michel Herbreteau in 1985 and is headquartered in Meylan, France. | Electronic Equipment/Instruments | Director/Board Member | |
Cellerix SA
![]() Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
Institut National de la Santé & de la Recherche Médicale
![]() Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member | |
ALTRAN TECHNOLOGIES | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Finbiomed SARL | Chief Executive Officer | ||
Thérapixel SA
![]() Thérapixel SA Packaged SoftwareTechnology Services Thérapixel SA designs software publisher for healthcare facilities. The company was founded by Olivier Clatz and Pierre Fillard in 2013 and is headquartered in Valbonne, France. | Packaged Software | Director/Board Member | |
Omnes Capital SAS /Venture/
![]() Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Investment Managers | Private Equity Investor | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree | |
Sofimac Innovation SAS
![]() Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Private Equity Investor | |
Turenne Capital Partenaires SA
![]() Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Physio-Assist SAS
![]() Physio-Assist SAS Medical SpecialtiesHealth Technology Physio-Assist SAS develops an expertise in bronchial mucus analysis and clearance. The company was founded by Adrien Mithalal on September 17, 2012 and is headquartered in Aix en Provence, France. | Medical Specialties | Director/Board Member | |
Amolyt Pharma SAS
![]() Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
Millendo Therapeutics SAS
![]() Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Director/Board Member | |
KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Intrexon ActoBiotics NV
![]() Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member | |
Covagen AG
![]() Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
TIGENIX NV | Medical Specialties | Director/Board Member | |
Knowings SA
![]() Knowings SA Packaged SoftwareTechnology Services Knowings SA develops software solutions for automation of processes of knowledge management and collaboration. It assists the integration of services with the help of intranet, extranet, and Internet. The company was founded by Patrick Michels in 1999 and is headquartered in Le Bourget du Lac, France. | Packaged Software | Director/Board Member | |
Smartesting Solutions & Services SAS
![]() Smartesting Solutions & Services SAS Packaged SoftwareTechnology Services Smartesting Solutions & Services SAS designs and develops software solutions to handle certification and testing of computer applications. It provides a certification approach that automates the production of required functional tests and helps reduce the risks of testing the most critical business applications. The company was founded in 2003 by Bruno Legeard and Laurent Py and is headquartered in Besancon, France. | Packaged Software | Director/Board Member |
Statistik
International
Frankreich | 36 |
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 3 |
Belgien | 3 |
Österreich | 2 |
Sektoral
Health Technology | 24 |
Technology Services | 11 |
Finance | 6 |
Consumer Services | 5 |
Commercial Services | 5 |
Operativ
Director/Board Member | 58 |
Chairman | 16 |
Corporate Officer/Principal | 15 |
Founder | 14 |
Chief Executive Officer | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Florent Aptel
- Unternehmensverbindungen